Business Context and Reporting Period
This Form 8-K Current Report was filed by DaVita Healthcare Partners Inc. on June 16, 2015. The report addresses a significant corporate governance event occurring on the same date, specifically regarding changes to the Board of Directors and executive leadership roles.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to Item 8.01 (Other Events) and contains no financial performance data.
Material Changes
- Leadership Restructuring: Kent J. Thiry, the Company's Chief Executive Officer, resumed his role as Chairman of the Company effective June 16, 2015.
- Board Composition: Dr. Robert J. Margolis was not re-nominated for election to the Board and was removed from his position as Co-Chairman immediately preceding the annual meeting of stockholders on June 16, 2015.
- Historical Context: Dr. Margolis had served as Co-Chairman alongside Mr. Thiry from November 2012 until June 16, 2015. Mr. Thiry previously served as Chairman from October 1999 through October 2012.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items. The document focuses exclusively on the administrative change in the Company's chairmanship.
Key Facts for Investor Verification
- Confirm the effective date of Kent J. Thiry's return to the Chairman role (June 16, 2015).
- Verify the removal of Dr. Robert J. Margolis from the Board and Co-Chairman position.
- Review subsequent filings for any financial impact or strategic shifts resulting from this leadership change.